231 related articles for article (PubMed ID: 7888528)
21. Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.
el-Helou P; Rachlis A; Fong I; Walmsley S; Phillips A; Salit I; Simor AE
Clin Infect Dis; 1997 Aug; 25(2):206-10. PubMed ID: 9332511
[TBL] [Abstract][Full Text] [Related]
22. Pott's disease associated with large and multiple abscesses in a 30-year-old migrant from Chad.
Conrad A; Ferry T; Ader F; Valour F;
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29378738
[No Abstract] [Full Text] [Related]
23. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
Roche B; Rozenberg S; Cambau E; Desplaces N; Dion E; Dubourg G; Koeger AC; Robin H; Vergeron H; Bourgeois P
Rev Rhum Engl Ed; 1997 Jan; 64(1):64-5. PubMed ID: 9051864
[No Abstract] [Full Text] [Related]
24. Pulmonary infection caused by Mycobacterium szulgai.
Pocza A
Med J Aust; 1981 Apr; 1(8):419-20. PubMed ID: 7254091
[TBL] [Abstract][Full Text] [Related]
25. Spinal infection by Mycobacterium xenopi in a non-immunosuppressed patient.
Rahman MA; Phongsathorn V; Hughes T; Bielawska C
Tuber Lung Dis; 1992 Dec; 73(6):392-5. PubMed ID: 1292722
[TBL] [Abstract][Full Text] [Related]
26. Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach.
Hornick DB; Dayton CS; Bedell GN; Fick RB
Chest; 1988 Mar; 93(3):550-5. PubMed ID: 3342664
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium xenopi isolation from clinical specimens in the Florence area: review of 46 cases.
Tortoli E; Simonetti MT; Labardi C; Lopes Pegna A; Meli E; Stanflin N; Susini S
Eur J Epidemiol; 1991 Nov; 7(6):677-81. PubMed ID: 1783061
[TBL] [Abstract][Full Text] [Related]
28. [Mycobacterium xenopi osteoarthritis of the ankle in a patient followed for psoriatic rheumatism].
Libbrecht E; Bressieux JM; Chélius P; Roger M; Eloy C; Rezzouk L; Fur A
Presse Med; 2000 Mar; 29(10):539-40. PubMed ID: 10761518
[TBL] [Abstract][Full Text] [Related]
29. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.
Manfredi R; Nanetti A; Morelli S; Ferri M; Valentini R; Calza L; Chiodo F
HIV Clin Trials; 2004; 5(4):206-15. PubMed ID: 15472795
[TBL] [Abstract][Full Text] [Related]
30. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada.
Damaraju D; Jamieson F; Chedore P; Marras TK
Int J Tuberc Lung Dis; 2013 May; 17(5):676-81. PubMed ID: 23575335
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Murray MP; Laurenson IF; Hill AT
Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
[TBL] [Abstract][Full Text] [Related]
32. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in Hungary.
Szlávik J; Sárvári C
Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):701-3. PubMed ID: 14557921
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics.
Cento V; Nava A; Lepera V; Torri S; Colagrossi L; Fanti D; Vismara C; Perno CF; Mazzola E
J Glob Antimicrob Resist; 2020 Sep; 22():533-537. PubMed ID: 32387259
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous infection with Mycobacterium xenopi.
Cutrona AF; Dixon DM
Cutis; 2001 Jan; 67(1):81-2. PubMed ID: 11204610
[No Abstract] [Full Text] [Related]
36. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.
Foudraine NA; Hovenkamp E; Notermans DW; Meenhorst PL; Klein MR; Lange JM; Miedema F; Reiss P
AIDS; 1999 Feb; 13(2):177-84. PubMed ID: 10202823
[TBL] [Abstract][Full Text] [Related]
37. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
38. Lung infection due to Mycobacterium xenopi: report of the first case in Japan.
Tsukamura M; Sekine K; Yokota A; Kuze A; Shibata M; Sato K
Microbiol Immunol; 1984; 28(1):123-7. PubMed ID: 6727712
[No Abstract] [Full Text] [Related]
39. Nontuberculous mycobacteria in the HIV infected patient.
Jones D; Havlir DV
Clin Chest Med; 2002 Sep; 23(3):665-74. PubMed ID: 12371002
[TBL] [Abstract][Full Text] [Related]
40. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi.
Costrini AM; Mahler DA; Gross WM; Hawkins JE; Yesner R; D'Esopo ND
Am Rev Respir Dis; 1981 Jan; 123(1):104-9. PubMed ID: 7458072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
